Key result
Ezetimibe or bile acid sequestrants produced the largest reductions in plasma sitosterol and LDL-cholesterol in subjects with sitosterolemia caused by ABCG5 or ABCG8 nonsense mutations.
Case Report (n=5)
Nonsense mutations in ABCG5 or ABCG8 cause sitosterolemia with a wide spectrum of vascular involvement, and plasma sterols are most effectively reduced by ezetimibe or bile acid sequestrants.
Answers are grounded in this paper and cite their sources.
Ezetimibe or bile acid sequestrants may warrant first consideration in sitosterolemia; leaves open confirmation in prospective trials.
Sitosterolemia is a rare autosomal recessive disorder of lipoprotein metabolism characterized by xanthomas and increased plasma concentrations of plant sterols, such as sitosterol. Causative mutations occur in either the ABCG5 or ABCG8 gene, each of which encodes a sterol half-transporter expressed in the intestine. We report five Canadian subjects with nonsense mutations in these half-transporters: four related Caucasian subjects were homozygous for the ABCG8 S107X mutation, and one unrelated Japanese-Canadian subject was homozygous for a complex insertion/deletion (I/D) mutation in ABCG5 exon 3. A female subject with each mutation was symptomatic with coronary atherosclerosis: a 5-year-old ABCG8 S107X homozygote and a 75-year-old ABCG5 exon 3 I/D homozygote; these represent the extreme ends of the spectrum of vascular involvement in sitosterolemia. The largest reductions in plasma concentrations of sitosterol and LDL-cholesterol were seen with ezetimibe or bile acid sequestrant treatment, and less dramatic reductions were seen with statin drug treatment. These findings extend the range of clinical phenotypes in sitosterolemia caused by nonsense mutations in either ABCG5 or ABCG8.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2004) conducted a case report in Sitosterolemia (n=5). Ezetimibe, bile acid sequestrants, or statins was evaluated on Plasma concentrations of sitosterol and LDL-cholesterol. Ezetimibe or bile acid sequestrants produced the largest reductions in plasma sitosterol and LDL-cholesterol in subjects with sitosterolemia caused by ABCG5 or ABCG8 nonsense mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: